[Use of the new hypotensive agent Minipress (prazosin hydrochloride]. 1982

V G Kukes, and S B Zisel'man, and G B Shustikova, and A S Rumiantsev, and E V Shagako

Efficacy of minipress in patients with hypertension stage II and its haemodynamic effects were studied after a single administration and during a course of treatment. It is shown that its main mechanism is in vasodilatation caused by relaxation of the muscular component of arterioles. The authors suggest that minipress can produce redistribution of the blood through peripheral venoconstriction. Decrease of the index of the external work of the heart points indirectly to decreased oxygen utilization by the myocardium which may reflect changes in haemodynamics under the influence of minipress or through direct action of the drug on the heart. Hypotensive effect of minipress is recorded already by the 5th day of its administration (p less than 0.001), however, its further effect is unstable. Increase of the circadian dose becomes necessary and also its combined use with thiazide diuretics. Positive chronotropic effect of Minipress has been recorded, with maximum towards the end of the 2nd week of treatment and seen as increased rate of cardiac contractions by 13.2% (p less than 0.01). To decrease this effect authors advise to use minipress in combination with beta-adrenoblockers.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V G Kukes, and S B Zisel'man, and G B Shustikova, and A S Rumiantsev, and E V Shagako
July 1977, JAMA,
V G Kukes, and S B Zisel'man, and G B Shustikova, and A S Rumiantsev, and E V Shagako
January 1977, Bollettino della Societa italiana di cardiologia,
V G Kukes, and S B Zisel'man, and G B Shustikova, and A S Rumiantsev, and E V Shagako
January 1977, Kardiologia polska,
V G Kukes, and S B Zisel'man, and G B Shustikova, and A S Rumiantsev, and E V Shagako
July 1979, Der Urologe. Ausg. A,
V G Kukes, and S B Zisel'man, and G B Shustikova, and A S Rumiantsev, and E V Shagako
April 1980, The Journal of the Maine Medical Association,
V G Kukes, and S B Zisel'man, and G B Shustikova, and A S Rumiantsev, and E V Shagako
January 1977, The Medical letter on drugs and therapeutics,
V G Kukes, and S B Zisel'man, and G B Shustikova, and A S Rumiantsev, and E V Shagako
August 1971, British journal of pharmacology,
V G Kukes, and S B Zisel'man, and G B Shustikova, and A S Rumiantsev, and E V Shagako
July 1977, Polski tygodnik lekarski (Warsaw, Poland : 1960),
V G Kukes, and S B Zisel'man, and G B Shustikova, and A S Rumiantsev, and E V Shagako
April 1976, The Medical journal of Australia,
V G Kukes, and S B Zisel'man, and G B Shustikova, and A S Rumiantsev, and E V Shagako
August 1989, The American journal of medicine,
Copied contents to your clipboard!